Steatorrhea medical therapy: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Management of [[steatorrhea]] include treatment of underlying etiology, control of [[diarrhea]] and correction of [[nutritional deficiencies]]. | Management of [[steatorrhea]] include treatment of underlying etiology, control of [[diarrhea]] and correction of [[nutritional deficiencies]].<ref name="pmid2509353">{{cite journal |vauthors=Marotta RB, Floch MH |title=Dietary therapy of steatorrhea |journal=Gastroenterol. Clin. North Am. |volume=18 |issue=3 |pages=485–512 |year=1989 |pmid=2509353 |doi= |url=}}</ref><ref name="pmid5917827">{{cite journal |vauthors= |title=Varieties of steatorrhea |journal=Br Med J |volume=2 |issue=5524 |pages=1214–5 |year=1966 |pmid=5917827 |pmc=1944784 |doi= |url=}}</ref><ref name="pmid8878143">{{cite journal |vauthors=Koch J, Garcia-Shelton YL, Neal EA, Chan MF, Weaver KE, Cello JP |title=Steatorrhea: a common manifestation in patients with HIV/AIDS |journal=Nutrition |volume=12 |issue=7-8 |pages=507–10 |year=1996 |pmid=8878143 |doi= |url=}}</ref> | ||
=== Correction of Nutritional Deficiencies === | === Correction of Nutritional Deficiencies === | ||
| Line 43: | Line 43: | ||
* For a detailed explanation of management of gallstones disease click [[Gallstone disease medical therapy|here]] | * For a detailed explanation of management of gallstones disease click [[Gallstone disease medical therapy|here]] | ||
* For a detailed explanation of management of cystic fibrosis disease click [[Cystic fibrosis medical therapy|here]] | * For a detailed explanation of management of cystic fibrosis disease click [[Cystic fibrosis medical therapy|here]] | ||
* For a detailed explanation of the management of small bowel bacterial overgrowth syndrome click [[Small intestinal bacterial overgrowth syndrome|here]] | * For a detailed explanation of the management of small bowel bacterial overgrowth syndrome click [[Small intestinal bacterial overgrowth syndrome|here]] | ||
==References== | ==References== | ||
Revision as of 18:38, 8 February 2018
|
Steatorrhea Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Steatorrhea medical therapy On the Web |
|
American Roentgen Ray Society Images of Steatorrhea medical therapy |
|
Risk calculators and risk factors for Steatorrhea medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Medical Therapy
Management of steatorrhea include treatment of underlying etiology, control of diarrhea and correction of nutritional deficiencies.[1][2][3]
Correction of Nutritional Deficiencies
- Oral supplementation with vitamins and minerals is usually well tolerated in patients who are are undergoing specified treatment for underlying etiology.
- Rapid recovery following the identification of a nutritional deficiency can be achieved by supplementation with 5 to 10 times the Recommended Dietary Allowance.
- Preferred regimen (1) : Vitamin A 40,000 to 50,000 units q12h
- Note : Maintenance: 8000 to 20,000 units/day (dosage ≥15,000 units can be teratogenic)
- Preferred regimen (2) : Vitamin D3 (cholecalciferol) 30,000 to 50,000 units q24h
- Preferred regimen (3) : Vitamin K 2.5 to 12.5 mg q24h
- Preferred regimen (4) : Folic acid 5 mg q24h during repletion
- Preferred regimen (5) : Vitamin B12 (cyanocobalamin) 1 mg subcutaneously
- Preferred regimen (6) : Ferrous sulfate 325 mg (65 mg elemental iron) q8h
- Preferred regimen (7) : Magnesium gluconate 1 to 4 g (54 to 216 mg elemental magnesium) q6h
- Preferred regimen (8) : Calcium carbonate 500 mg (elemental calcium) q12h
- Preferred regimen (1) : Vitamin A 40,000 to 50,000 units q12h
Antidiarrheal agents
- Preferred regimen (1) : Loperamide 2 to 4 mg as needed, not to exceed 12 mg/day
- Preferred regimen (1) : Diphenoxylate with atropine (Lomotil) 1 to 2 tabs after loose stool, not to exceed 8 per day
- Preferred regimen (1) : Deodorized opium tincture 10 percent (10 mg per mL) 0.3 to 0.6 mL q8h
Bile acid binding resins
- Preferred regimen (1) : Cholestyramine 4 g three times daily
- Preferred regimen (1) : Colestipol granules 5 to 10 g three times daily
- Note: Administer ≥1 hour before or >4 hours after other drugs to prevent decreased absorption of other drugs.
Pancreatic enzymes
- Preferred regimen (1) : Pancrelipase delayed-release capsules (Creon minimicrospheres)
- Preferred regimen (1) : Pancrelipase tablets and powder (Viokase) 1 g
- (equivalent to 20,000 units lipase component) with meals
- Note: Approximately 30,000 units (90,000 USP) (lipase component) with each meal
Management of Underlying Etiologies
- For a detailed explanation of management of Crohn's disease click here
- For a detailed explanation of management of celiac disease click here
- For a detailed explanation of management of gallstones disease click here
- For a detailed explanation of management of cystic fibrosis disease click here
- For a detailed explanation of the management of small bowel bacterial overgrowth syndrome click here
References
- ↑ Marotta RB, Floch MH (1989). "Dietary therapy of steatorrhea". Gastroenterol. Clin. North Am. 18 (3): 485–512. PMID 2509353.
- ↑ "Varieties of steatorrhea". Br Med J. 2 (5524): 1214–5. 1966. PMC 1944784. PMID 5917827.
- ↑ Koch J, Garcia-Shelton YL, Neal EA, Chan MF, Weaver KE, Cello JP (1996). "Steatorrhea: a common manifestation in patients with HIV/AIDS". Nutrition. 12 (7–8): 507–10. PMID 8878143.